The pregnancy is told as a rare event among End-stage Renal Disease (ESRD) women undergoing chronic Hemodialysis (HD). This is mainly due to ESRD to be considered per se as a powerful method of contraception and sexual dysfunction is higher in women undergoing HD likely as a result of the cumulative effects of depression, fatigue, altered body image, medication side effects and premature menopause, and the gestation in these women is frequently associated with poor fetal outcomes.

However, in last years the number of gestations among patients undergoing HD is increasing exponentially around the world, associated with better fetal outcome secondary to improvement in dialysis management during gestation. A systematic review and meta-analysis in pregnancy on dialysis patients regarding the period between 2000 and 2008 collected series of at least 5 cases included 90 pregnancies and when the period was increased in 6 years (from 2000 to 2014) more than 600 pregnancies were included, probably related to the great progress that has been made in the care of HD patients with widespread use of biocompatible membranes, greater dialysis dose and erythropoiesis stimulating agents.

The Journal of Clinical Nephrology and Therapeutics  publishes scientific manuscripts that are directly or indirectly based on variegated aspects of clinical nephrology, diabetic nephropathy, pediatric nephrology, renal physiology, renal histopathology, immunobiology, intensive care nephrology and ischemic nephropathy.

The journal most specifically emphasizes on the propagation of research developments that may contribute in the furtherance of research and clinical implementation of novel tools as well as adept clinical techniques including renal transplantation, dialysis, diagnostic kidney imaging, aging and kidney disease, hemodialysis, body fluid volume composition, nephron endowment and erythropoietin therapy.

The journal accepts original submissions in the form of Research Articles, Review Articles, Short Communications, Opinion Articles, Case Reports and Commentaries. Acceptance or rejection of the manuscript solely depends upon the comments of independent reviewers. Positive review by at least two reviewers is mandatory for the acceptance and publication of any citable manuscript.

You may submit manuscripts as an email attachment to the following mail-id: clinnephrol@emedscholar.com

Kind Regards,
Mercedes Rose
Managing Editor
Journal of Clinical Nephrology and Therapeutic
WhatsApp: +44-1470-490003